Literature DB >> 21810051

Chronic Lyme disease: the controversies and the science.

Paul M Lantos1.   

Abstract

The diagnosis of chronic Lyme disease has been embroiled in controversy for many years. This is exacerbated by the lack of a clinical or microbiologic definition, and the commonality of chronic symptoms in the general population. An accumulating body of evidence suggests that Lyme disease is the appropriate diagnosis for only a minority of patients in whom it is suspected. In prospective studies of Lyme disease, very few patients go on to have a chronic syndrome dominated by subjective complaints. There is no systematic evidence that Borrelia burgdorferi, the etiology of Lyme disease, can be identified in patients with chronic symptoms following treated Lyme disease. Multiple prospective trials have revealed that prolonged courses of antibiotics neither prevent nor alleviate such post-Lyme syndromes. Extended courses of intravenous antibiotics have resulted in severe adverse events, which in light of their lack of efficacy, make them contraindicated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810051     DOI: 10.1586/eri.11.63

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  22 in total

Review 1.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

Review 2.  Unorthodox alternative therapies marketed to treat Lyme disease.

Authors:  Paul M Lantos; Eugene D Shapiro; Paul G Auwaerter; Phillip J Baker; John J Halperin; Edward McSweegan; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2015-04-06       Impact factor: 9.079

3.  A Learner-led, Discussion-based Elective on Emerging Infectious Disease.

Authors:  Clinton Mathias
Journal:  Am J Pharm Educ       Date:  2015-08-25       Impact factor: 2.047

4.  Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

5.  Misdiagnosis of late-onset Lyme arthritis by inappropriate use of Borrelia burgdorferi immunoblot testing with synovial fluid.

Authors:  Sam S Barclay; Michael T Melia; Paul G Auwaerter
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

Review 6.  Clinical practice. Lyme disease.

Authors:  Eugene D Shapiro
Journal:  N Engl J Med       Date:  2014-05-01       Impact factor: 91.245

Review 7.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

8.  DNA persistence after treatment of Lyme borreliosis.

Authors:  D Pícha; L Moravcová; D Vaňousová; J Hercogová; Z Blechová
Journal:  Folia Microbiol (Praha)       Date:  2013-08-09       Impact factor: 2.099

9.  Bullying Borrelia: when the culture of science is under attack.

Authors:  Paul G Auwaerter; Michael T Melia
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

10.  The musculoskeletal abnormalities of the Similaun Iceman ("ÖTZI"): clues to chronic pain and possible treatments.

Authors:  Walter F Kean; Shannon Tocchio; Mary Kean; K D Rainsford
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.